PhD Candidate
Vanderbilt University
Nashville, Tennessee, United States
Lucinda Pastora is PhD candidate in the Department of Chemical and Biomolecular Engineering at Vanderbilt University, where she works in Dr. John Wilson’s Immunoengineering Lab. In the Wilson lab, she is exploring STING pathway inhibition via intravenous or oral administration of inhibitor-loaded nanoparticles for the treatment of STING-driven inflammatory conditions, including colitis. She is also investigating the effect of cGAS/STING activation and blockade on the immune microenvironment of the colon. Her broad interests include biomaterials, nanotechnology, and the delivery of immunotherapeutics. Lucinda completed her undergraduate degree in Chemical and Biological Engineering at Princeton University in 2018, earning certificates in both Materials Science and Engineering Biology. Lucinda's senior thesis focused on improving the growth rate and density of marine algae in bioreactors through the introduction of nanoparticle-encapsulated fluorescent dyes; this work was conducted under the supervision of Dr. Jose Avalos and Dr. Bob Prud'homme. Lucinda is the recipient of an NIH T32, NSF Graduate Research Fellowship, Provost Graduate Fellowship, Harold Stirling Vanderbilt Award, and she is a 2023 SMDP Biotech Scholar.
Disclosure information not submitted.
Poster CC18 - Glioblastoma Immunotherapy using RIG-I Activating Nanoparticles
Thursday, October 24, 2024
2:45 PM – 3:45 PM EST